NCT01339325

Brief Summary

The aim of this study is to assess possible differences between the LESS approach and the standard laparoscopic approach to cholecystectomy. In particular, the Postoperative Quality of Life (QoL) will be investigated by analyzing the followings: length of hospital stay (LoS), postoperative pain, cosmetics and the results of SF 36 questionnaire. Furthermore, operative time, conversion to standard LC rate, difficulty of exposure, difficulty of dissection, and complication rate will be compared.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started May 2011

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2011

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 20, 2011

Completed
11 days until next milestone

Study Start

First participant enrolled

May 1, 2011

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2012

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

April 20, 2011

Status Verified

March 1, 2011

Enrollment Period

1.3 years

First QC Date

March 30, 2011

Last Update Submit

April 19, 2011

Conditions

Keywords

Laparo-endoscopic single site cholecystectomyQuality of LifePostoperative PainCosmeticsComplication

Outcome Measures

Primary Outcomes (1)

  • Postoperative Quality of Life (QoL)

    Postoperative Quality of Life (QoL) will be the primary endpoint: QoL will be assessed analysing the followings: length of hospital stay (LoS), postoperative pain, cosmetics and the results of SF 36 questionnaire.

    one month

Secondary Outcomes (5)

  • operative time

    day 1

  • conversion rate to standard LC

    day 1

  • surgeon perception of difficulty of exposure measured with a Visual Analog Scale (VAS) with 0 to the least difficult and 5 to the most difficult

    day 1

  • surgeon perception of difficulty of dissection measured with a Visual Analog Scale (VAS) with 0 to the least difficult and 5 to the most difficult

    day 1

  • complication rate

    one month

Study Arms (3)

LESS cholecystectomy

ACTIVE COMPARATOR

Laparo-endoscopic single site cholecystectomy, the entire surface of the patient's abdomen is covered by plaster at the end of the operation. Patient does not know which kind of procedure he underwent before discharge.

Procedure: Cholecystectomy

Standard LAP-CHOLE

ACTIVE COMPARATOR

Standard laparoscopic cholecystectomy. The entire surface of the patient's abdomen is covered by plaster at the end of the operation. Patient does not know which kind of procedure he underwent before discharge.

Procedure: Cholecystectomy

LESS Cholecystectomy not blind

ACTIVE COMPARATOR

Laparo-endoscopic single site cholecystectomy. The patient is aware of the procedure he underwent.

Procedure: Cholecystectomy

Interventions

Standard laparoscopic cholecystectomy The first cannula is inserted with an "open laparoscopy" technique. LCs are performed with either HF or US energized dissection, standard or fundus-first gallbladder dissection, closure of the artery by ligature/clip or US, closure of cystic duct by ligature/clip. Laparo-endoscopic single site cholecystectomy The TriPort device is inserted at the navel site through a 15 to 25 mm incision with an "open laparoscopy" technique. Two working instruments are inserted (one grasper and one energised device) through the TriPort. A further 1.8 or 3 mm instrument inserted through the larger gel valve, parallel to a 5 mm dissecting instrument, is used in some cases to enhance exposure. Gallbladder dissection is accomplished either after preparation of the cystic duct and artery or with a fundus-first technique, by means of HF electrosurgery or US shears.The cystic artery is divided between clips or by US scissors. The duct is divided between clips.

LESS Cholecystectomy not blindLESS cholecystectomyStandard LAP-CHOLE

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18-75
  • BMI \< 35
  • no previous upper GI or right colonic surgery with severe adhesions gallstones with absence of clinical signs of acute cholecystitis, bile duct stones or pancreatitis.
  • ASA I-III
  • Nassar grade of difficulty in performing a laparoscopic cholecystectomy I-III
  • diagnosis: cholelithiasis

You may not qualify if:

  • cholecystitis
  • existence of common duct stones
  • presence of biliary cancer
  • Previous abdominal surgery on organs of the supramesocolic space

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

San Giovanni Hospital

Rome, Lazio, 00184, Italy

Location

Related Publications (1)

  • Steinemann DC, Raptis DA, Lurje G, Oberkofler CE, Wyss R, Zehnder A, Lesurtel M, Vonlanthen R, Clavien PA, Breitenstein S. Cosmesis and body image after single-port laparoscopic or conventional laparoscopic cholecystectomy: a multicenter double blinded randomised controlled trial (SPOCC-trial). BMC Surg. 2011 Sep 12;11:24. doi: 10.1186/1471-2482-11-24.

MeSH Terms

Conditions

CholelithiasisPain, Postoperative

Interventions

Cholecystectomy

Condition Hierarchy (Ancestors)

Biliary Tract DiseasesDigestive System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Biliary Tract Surgical ProceduresDigestive System Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Marco Maria Lirici, FACS

    San Giovanni Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marco Maria Lirici, FACS

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 30, 2011

First Posted

April 20, 2011

Study Start

May 1, 2011

Primary Completion

September 1, 2012

Study Completion

December 1, 2012

Last Updated

April 20, 2011

Record last verified: 2011-03

Locations